Hans-Joachim Schmoll, Laura Van't Meer, Jan Vermorken, Dirk Schrijvers

"The editors and authors of the ESMO Handbook have produced a truly remarkable handbook [...] It is highly recommended for use by both residents and fellows in medical and in radiation oncology and by attending oncologists themselves. Program directors would be well advised to provide a copy of this manual to all trainees entering their program."John E. Munzenrider, M.D., Massachussets General Hospital, Boston, MA

• 1. Introduction 2. Pathology 3. Biomarkers in oncology 4. Radiological imaging 5. Nuclear medicine imaging 6. Staging procedures 7. Prognostic criteria 8. Predictive tumor markers 9. Factors determining anticancer treatment 10. Treatment evaluation of activity: From global to personalized approach 11. Acute and subacute toxicities of medical anticancer treatment 12. Late toxicity 13. Acute and late effects in radiation oncology and surgery 14. Psychosocial effects of cancer and treatment 15. Incapacity due to cancer and cancer therapy 16. Reintegration into the workplace 17. Quality of life issues 18. Conclusion

Hans-Joachim Schmoll, Laura Van't Meer, Jan Vermorken, Dirk Schrijvers

"The editors and authors of the ESMO Handbook have produced a truly remarkable handbook [...] It is highly recommended for use by both residents and fellows in medical and in radiation oncology and by attending oncologists themselves. Program directors would be well advised to provide a copy of this manual to all trainees entering their program."John E. Munzenrider, M.D., Massachussets General Hospital, Boston, MA

• 1. Introduction 2. Pathology 3. Biomarkers in oncology 4. Radiological imaging 5. Nuclear medicine imaging 6. Staging procedures 7. Prognostic criteria 8. Predictive tumor markers 9. Factors determining anticancer treatment 10. Treatment evaluation of activity: From global to personalized approach 11. Acute and subacute toxicities of medical anticancer treatment 12. Late toxicity 13. Acute and late effects in radiation oncology and surgery 14. Psychosocial effects of cancer and treatment 15. Incapacity due to cancer and cancer therapy 16. Reintegration into the workplace 17. Quality of life issues 18. Conclusion